Moderate riskFDA DrugClass II

Excedrin 2's pain reliever recalled for insanitary conditions and rodent exposure

Excedrin 2's pain reliever tablets distributed by Gold Star Distribution have been recalled due to insanitary conditions found at their distribution center, including evidence of rodent activity. All unexpired batches distributed by this company are affected. No injuries have been reported so far.

From the FDA notice · Read the official notice ↗ · All Gold Star Distribution recalls

What to do

  1. Check your medicine cabinet for Excedrin 2's distributed by Gold Star Distribution
  2. Do not use any boxes or packages you find
  3. Dispose of the product safely or return it to the retailer where you purchased it

Is yours affected?

Compare your label or packaging with the recalled product.

Product
EXCEDRIN 2'S DISP.- 30 CT
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 27 products — see all of them.

Details

Illnesses reported
None reported
Manufactured in
1000 Humboldt Ave N, Minneapolis, MN, United States
Classification
Class II
Recall number
D-0269-2026

In the FDA's words

Description
EXCEDRIN 2'S DISP.- 30 CT CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. All lots within expiry distributed by Gold Star Distribution. Distribution: US Nationwide.
Hazard
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

27 products in this recall

Advil, Tylenol and more OTC medicines recalled for rodent exposure

Gold Star Distribution is recalling 27 over-the-counter products, including pain relievers, cold and flu medicines, antacids, cough drops, skin and lip care, petroleum jelly, rubbing alcohol and mouthwash. The products were stored or distributed from a facility with insanitary conditions, including rodent exposure and activity. No injuries have been reported.

The agency lists each product separately. Check every one you might have.

Related topics

OtherDrugsSold nationwideMore from FDA Drug